The global acute kidney injury treatment market size surpassed at US$ 1.4 bn in 2020 and to reach US$ 2.6 billion by 2028 with a rising CAGR of 7.2% from 2021 to 2028.
The acute kidney injury treatment market report suggests that, increase in the geriatric population and rising incidences of acute kidney injuries are expected to propel the acute kidney injury treatment market. North America is expected to be a prominent region in the global acute kidney injury treatment market, owing to the rise in the patient population, high geriatric population, and increasing technological advancements.
The acute kidney injury treatment market in Asia Pacific is expected to expand at a CAGR of around 8% during the forecast period, due to the increasing geriatric population, developing healthcare infrastructure, and growing patient population in the region.
Moreover, research and development activities and initiatives by governments in the healthcare sector are anticipated to further enhance the acute kidney injury treatment market in Asia Pacific.
Dialysis Segment Projected to be a Highly Lucrative Segment in the Acute Kidney Injury Treatment Market
Prerenal Acute Kidney Injury Segment Holds a Prominent Share in the Acute Kidney Injury Treatment Market
North America Holds Sway, whereas Asia Pacific Emerging as a Lucrative Market
Development of Technologically-Advanced Acute Kidney Injury Treatment Options and Strategic Collaborations and Acquisitions are Key Strategies Adopted by Leading Players
Market Segmentation
By Type
Prerenal Acute Kidney Injury
Postrenal Acute Kidney Injury
Intrinsic Renal Acute Kidney Injury
By Treatment
Dialysis
Supportive Care
By End User
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
Europe
Latin America
Asia Pacific
Middle East and Africa
Report Scope
Vision Research Reports has recently published a new report on the global acute kidney injury treatment market. The report gives complete information on the acute kidney injury treatment market, and elaborates on the significant factors that are influencing the growth of the acute kidney injury treatment market during the period of 2021 to 2028. Special focus has been given to drivers, restraints, opportunities, and threats (DROTs) to research on the acute kidney injury treatment market with a holistic view. Moreover, emphasis has been put on the demand side as well as the supply side, as both are equally responsible for the growth of the acute kidney injury treatment market.
The changing dynamics in the healthcare sector across the globe, especially when treatment is provided for kidney injury, has encouraged researchers to amalgamate information in a systematic manner. This will help key players operating in the acute kidney injury treatment market to take well-analyzed and systematic decisions in the near future. The presentation of information has been done in a systematic form, which includes theory and statistics. Acute kidney injury treatment market growth has been presented, both, in terms of value and volume, as per requirement.
Readers will enrich their knowledge on the acute kidney injury treatment market based on the information presented in this report. Geographical insights and competitors’ information will also help the readers in taking better decisions, keeping in mind the growth of their businesses. Besides, segments indicating the growth of a specific product have also been mentioned in the acute kidney injury treatment market report.
Key Questions Answered
Analysts of the report focused on answering some key questions about acute kidney injury treatment. This is to help readers gain clear knowledge about growth in the acute kidney injury treatment market, and what are the ongoing changes taking place that will diversify the market in the coming years.
Research Methodology Adopted for the Acute Kidney Injury Treatment Market Report
To provide 360-degree insights on the acute kidney injury treatment market, researchers have followed both, the top-down approach and bottom-up approach. As there is no specific drug available in the market, researchers conducted one-on-one interviews with leading industry players, CEOs, presidents, chairmen, directors, vice presidents, and business consultants. Additionally, modeling techniques were used to produce comprehensive data sets. During secondary research, information was collected from different sources, including white papers, journals, and magazines published by NCBI – National Center for Biotechnology Information, Forbes, besides others. Data from organizations and institutions was also gathered, such as the World Health Organization, EMA - European Medicines Agency, CDC- Centers for Disease Control & Prevention, and a few others.